Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling of Counterfeit Products

Posted on By

Standard Operating Procedure for Handling of Counterfeit Products

Purpose

The purpose of this SOP is to establish procedures for the identification, quarantine, and reporting of counterfeit products within the pharmaceutical distribution facility, ensuring compliance with regulatory requirements and safeguarding patient safety and product integrity.

Scope

This SOP applies to all personnel involved in the receipt, storage, handling, and distribution of pharmaceutical products within the facility, as well as those responsible for quality assurance and regulatory compliance.

Responsibilities

  • The Quality Assurance Manager is responsible for overseeing procedures related to the identification and handling of counterfeit products and ensuring compliance with regulatory requirements.
  • The Warehouse Supervisor is responsible for monitoring incoming shipments for signs of counterfeit products and taking appropriate action if counterfeit products are identified.
  • All personnel are responsible for adhering to procedures outlined in this SOP and reporting any suspected counterfeit products to the Quality Assurance Manager or Warehouse Supervisor.
See also  SOP for Destruction of Expired or Rejected Products

Procedure

  1. Identification of Counterfeit Products:
    • Train personnel on the identification of counterfeit products, including common signs of counterfeiting such as suspicious packaging, labeling discrepancies, and unusual appearance or markings.
    • Implement procedures for inspecting incoming shipments for signs of counterfeiting, including verification of product authenticity through available resources such as manufacturer databases or authentication technologies.
  2. Quarantine and Segregation:
    • If counterfeit products are suspected or identified,
quarantine the products immediately to prevent distribution or use.
  • Segregate counterfeit products from genuine products to avoid mixing or accidental distribution.
  • Notification and Reporting:
    • Notify the relevant authorities, such as regulatory agencies and law enforcement, immediately upon identification of counterfeit products.
    • Document all relevant information regarding the suspected counterfeit products, including product details, quantity, supplier information, and any supporting evidence.
  • Investigation and Disposition:
    • Conduct a thorough investigation into the suspected counterfeit products to determine the source and extent of the counterfeiting activity.
    • Collaborate with regulatory authorities and other stakeholders to coordinate actions for disposition of counterfeit products, including disposal or return to the supplier.
  • Training and Awareness:
    • Provide regular training to personnel on procedures for identifying and handling counterfeit products and the importance of reporting suspicious activities.
    • Ensure that personnel are aware of the potential risks associated with counterfeit products and understand their role in preventing their distribution.
  • Abbreviations

    • SOP – Standard Operating Procedure

    Documents

    Reference documents related to handling of counterfeit products may include:

    • Counterfeit product identification guidelines
    • Incident reports
    • Regulatory notifications
    • Investigation findings
    • Training records

    Reference

    Good Distribution Practice Guidelines

    SOP Version

    Version 1.0

    See also  SOP for Receiving and Acceptance of Goods
    Good Distribution Practice Tags:Cold chain management, Controlled drug handling regulations, Distribution logistics, Distribution quality control, Distribution quality management, GDP audit, GDP certification, GDP compliance, GDP guidelines, GDP regulations, GDP training, Good Distribution Practice SOPs, Good Distribution Practice training, Pharmaceutical distribution, Pharmaceutical distribution standards, Pharmaceutical logistics, Pharmaceutical supply chain, Regulatory compliance in distribution, Storage conditions monitoring, Temperature mapping, Temperature-controlled logistics, Transportation validation, Warehousing best practices

    Post navigation

    Previous Post: How do SOP’s contribute to the documentation and investigation of quality incidents or deviations in pharmaceutical manufacturing?
    Next Post: SOP for Management of Quarantine Areas

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version